Immunohelix
Seattle, US · 2 known investors
NapaJen Pharma is a biopharmaceutical research and development company developing nucleic acid (oligonucleotide) drugs using a proprietary cell-specific drug delivery platform that enables delivery to immune cells for precision-targeted immunosuppression and controlled immuno-stimulation. It develops its own drug candidates and partners with other pharmaceutical companies applying its delivery technology.
Founders & leadership
有
有馬賢治CEO & Director (NapaJen Pharma, Inc.); Representative Director (NapaJen Pharma K.K.)
Investors · 2
Frequently asked questions
- What does Immunohelix do?
- NapaJen Pharma is a biopharmaceutical research and development company developing nucleic acid (oligonucleotide) drugs using a proprietary cell-specific drug delivery platform that enables delivery to immune cells for precision-targeted immunosuppression and controlled immuno-stimulation. It develops its own drug candidates and partners with other pharmaceutical companies applying its delivery technology.
- Who are Immunohelix's investors?
- Immunohelix's investors include RDiscovery, Remiges Ventures, Inc..
- Where is Immunohelix headquartered?
- Immunohelix is headquartered in Seattle, US.